Nemera: Drug delivery devices

Safe'n'Spray: winner at CPhI Festival of Pharma
We’re delighted to share that our concept device Safe'n'Spray was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on October 13 on the digital platform of CPhI Festival of Pharma.
Read more about Safe'n'Spray
Our booth is digital but our connection is real!
Nemera is at the forefront of this transformation. We are convinced it is the best way to move forward and continue to serve customers and patients. Discover our digital booth, live the experience and join us on our journey!
Discover our digital booth
Join Nemera at CPhI Festival of Pharma
CPhI Festival of Pharma will take place from 5-16 October 2020. First of its kind, this digital event will bring the global pharma industry to our doorstep. Nemera will be part of this event to connect with peers, learn from the industry and share our expertise.
Register for free now!

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries

We leverage a long standing experience to provide you leading-edge drug delivery devices
for different application areas, from design to large scale manufacturing.

Device design & development

World Class Innovation Center: we are passionate to develop the best solutions
Learn more

100% quality focused manufacturing

Global GMP manufacturing capabilities and strong continuous improvement culture
Learn more

A wide range of drug delivery devices for every application

Ophthalmic Preservative-free multidose eye dropper
Ophthalmic
Nasal spray bioequivalence
Ear, Nose, Throat
Passive safety system for prefilled syringes
Parenteral
Airless dispenser for dermal topical delivery
Dermal
Inhaler for astham and COPD
Inhalation

Our latest news

Contact us

E-mail: information@nemera.net

This form collects your name and email so that we can send you your requested content. Check out our legal notices for more details.

Linkedin-in
Twitter
Youtube